Medical Research News

RSS

CBD may help reduce cytokine storm and excessive lung inflammation in COVID-19

Cannabidiol, or CBD, may help reduce the cytokine storm and excessive lung inflammation that is killing many patients with COVID-19, researchers say.

16 Jul 2020

Preoperative test may help protect language centers during brain tumor removal

A technique that maps a patient's language centers before going into surgery works best when their brain tumor is not in those areas.

16 Jul 2020

Weak immune status, and not HIV infection affects cavity prevalence in children

Recent studies indicate HIV infection heightens the risk of dental cavities - but a Rutgers researcher has found evidence that the risk of cavities comes not from HIV itself but from a weakened immune system, which could be caused by other diseases.

16 Jul 2020

Multiple social disadvantages can amplify stroke risk, study shows

Having more social disadvantages can nearly triple your risk of stroke, particularly if you are under the age of 75, according to new research published today in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.

16 Jul 2020

Study: Rate of recurrent strokes is significantly declined among Mexican Americans

The rate of recurrent strokes significantly declined among Mexican Americans in a long-term study, according to new research published today in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.

16 Jul 2020

Study shows how parasitic bacteria cause lesions in the skin and internal organs

Bacteria of the genus Bartonella are parasites that can be transmitted to humans via insect bites and animal scratches, resulting in an infection known as "bartonellosis."

16 Jul 2020

Study could accelerate drug development to reduce age-related diseases

Genes linked to ageing that could help explain why some people age at different rates to others have been identified by scientists.

16 Jul 2020

Prominent pharmacologist calls for new approach to treat COVID-19

A prominent Australian pharmacologist has called for a new approach to treating COVID-19 as hopes fade of finding an effective vaccine or antiviral before the end of the year.

16 Jul 2020

Study shows how radiotherapy alters the behavior of immune cells in glioblastoma tumors

A Ludwig Cancer Research study has dissected how radiotherapy alters the behavior of immune cells known as macrophages found in glioblastoma (GBM) tumors and shown how these cells might be reprogrammed with an existing drug to suppress the invariable recurrence of the aggressive brain cancer.

16 Jul 2020

Dopaminergic neurones behave differently in different animals, shows study

Animals have an innate preference for certain scents and tastes. Attractive scents are linked to things like good food.

16 Jul 2020

Researchers identify distinct immune profiles in COVID-19 patients

Expanding on observations made in smaller patient cohorts, researchers studying immune responses of 125 hospitalized COVID-19 patients identified distinct immune profiles -- "Immunotypes" -- and showed how these signatures correlated with disease severity.

16 Jul 2020

Selective statins may reduce SARS-CoV-2 cell entry and inhibit infection

Statins are a class of drugs often used to control high cholesterol levels in obesity. Now, a study published on the preprint server medRxiv* in July 2020 suggests that statins do not aggravate the risk of COVID-19 infection and may have a small beneficial effect in some cases.

16 Jul 2020

How do international travel bans effect local COVID-19 epidemics?

Now, a new study published in July 2020 on the preprint server medRxiv* shows that the latter is likely to cause 90% or more of local epidemics and that stringent bans on international travelers are therefore unlikely to affect the course of the local outbreak significantly.

16 Jul 2020

Massive study looks at history of COVID-19 in Catalonia, Spain

A massive and important new study published on the preprint server medRxiv* in July 2020 sets out a comprehensive picture of the COVID-19 outbreak in Catalonia, Spain. It fills in a void in the current research, with its grand scale and detailed analysis.

16 Jul 2020

Children with MIS-C have different antibody responses than adults with COVID-19

A new study published on the preprint medRxiv in July 2020 reveals that children with the condition Multisystem Inflammatory Syndrome in Children (MIS-C) have a distinctly different pattern of antibody generation compared to adults with COVID-19 disease.

16 Jul 2020

Evidence of SARS-CoV-2 placental infection in mild COVID-19

Now, a new study published on the preprint server medRxiv* in July 2020 reveals evidence of placental infection and hypoxia, despite the lack of serious symptoms in the mother.

16 Jul 2020

Likelihood of SARS-CoV-2 transmission may depend on blood type of spreader and recipient

A modeling study by Dr. Peter Ellis from the University of Kent indicates that ABO incompatibility between infected patients and susceptible individuals may actually decrease the transmissibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by 60% or more. His detailed investigation of such "ABO-interference" can be found on the medRxiv preprint server.

15 Jul 2020

Latent tuberculosis infection in European countries closely correlates with COVID-19 infection

In a recent medRxiv preprint research paper, scientists from India analyzed twenty European countries and showed that the prevalence of exposure to Mycobacterium spp. (which includes BCG vaccine) is consistently negatively correlated with coronavirus disease (COVID-19) infections.

15 Jul 2020

Peptide-derived nanoparticle drug shows promise for treating heart attack

Researchers at the University of Illinois at Chicago have developed a new drug that prevents blood clots without causing an increased risk of bleeding, a common side effect of all antiplatelet medications currently available.

15 Jul 2020

Study finds significant variability in the accuracy of currently available COVID-19 antibody tests

A new peer-reviewed study by researchers at NSF International and Novateur Ventures finds significant variability in the accuracy of currently available COVID-19 antibody tests.

15 Jul 2020